Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Wo2010029082a1 example 15 alpelisib patent google patents?

See the DrugPatentWatch profile for alpelisib

What is WO2010029082A1 “Example 15,” and why does it matter for alpelisib?

WO2010029082A1 is a patent application published in 2010 (PCT publication number format: WO + year + number + A1). To verify what “Example 15” contains and whether it relates to alpelisib specifically, you need the exact document text from Google Patents (or another full-text source). The snippet details (like “Example 15”) can vary in meaning depending on the document’s claims, embodiments, and how examples are numbered in the published PDF.

Because you asked for “WO2010029082A1 example 15 alpelisib patent google patents,” the key thing is to locate Example 15 inside the Google Patents page for WO2010029082A1, then cross-check whether the example explicitly names alpelisib (or uses a chemical structure name/identifier that maps to alpelisib).

Where to find “Example 15” on Google Patents for WO2010029082A1

On Google Patents, you can usually:
1. Open the patent page for WO2010029082A1.
2. Use the in-page search (Ctrl+F / Cmd+F) for “Example 15”.
3. Confirm whether the example text includes:
- the compound name “alpelisib,”
- an IUPAC/systematic name that matches alpelisib,
- or a preparation/compound formula that corresponds to alpelisib’s known structure.

If you paste the “Example 15” text here (or upload a screenshot of that section), I can map it directly to alpelisib and tell you what part of the example lines up with alpelisib (or whether it is about a different PI3K inhibitor class).

Does WO2010029082A1 “Example 15” actually mention alpelisib?

Most patent documents won’t mention “alpelisib” by brand name unless the filing explicitly targeted that specific drug (or a close chemical analogue) and did so by name in the text. Many chemistry patents describe families of PI3K inhibitors with generic numbering (examples, compounds, intermediates), which can include alpelisib-like structures without using the later INN/brand name “alpelisib.”

To answer this precisely for your requested example, I need the “Example 15” content (or a direct link to the exact Google Patents “Example 15” text block).

If Example 15 is about a compound family, how do you confirm it’s alpelisib?

Common ways to confirm:
- The example’s compound name matches alpelisib’s systematic/IUPAC name.
- The example includes a structural description (formula/SMILES/inchi) that matches alpelisib.
- The example references an intermediate or final compound number that is later used as the same active ingredient in other parts of the patent.

Without the actual “Example 15” text, I can’t reliably state that it corresponds to alpelisib.

Can you share the Google Patents link or the Example 15 text?

If you provide either:
- the Google Patents URL for WO2010029082A1, or
- the exact text of “Example 15” (and any listed compound numbers),
I can extract what Example 15 describes and tell you whether it’s an alpelisib preparation/embodiment, an intermediate, or a different compound from the same broader family.



Other Questions About Alpelisib :

Alpelisib synthesis patent 2009 novartis wo 2009? Us patent application alpelisib novartis 2009? Alpelisib synthesis patent novartis 2009 wo? Alpelisib patent synthesis 2009 novartis ag? Novartis ag patent 2009 alpelisib synthesis? Alpelisib synthesis patent wo 2010 novartis example? Alpelisib patent synthesis novartis 2009 wo?